The novel treatment of tirzepatide peptide represents a significant breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide010106.blogchaat.com/42309115/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment